Testred Articles
Solvay's 2005 revenue reaches 8.5 B euros
27 February 2006
Solvay under pressure as FDA probes HRT
21 April 2003
US Court Rules For Solvay In Sage Suit Over Menogen
4 February 1998
SB's UK Launch With Testosterone Patch
12 August 1996
WORLD PRODUCT NEWS IN BRIEF
24 January 1994
HORMONE REPLACEMENT THERAPY: US REPORT
8 June 1992
Showing 1-6 of 6 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
